INDUSTRY NEWS

Stay up-to-date on the latest industry, member, and policy related news.

MichBio members can submit news to be shared here, on our social media, and in our monthly newsletter.

Cayman Develops Powerful Multiplex ELISA for Autoantibody Detection

June 1, 2021

ANN ARBOR, MI, May 11, 2021 — Cayman Chemical’s new Q-Plex™ Autoantibody Detection 10-Plex Panel, developed in collaboration with Quansys Biosciences, offers standardized, multiplex capabilities for the concurrent analysis of ten prominent analytes associated with rheumatoid arthritis or other autoimmune diseases. This new qualitative, chemiluminescent ELISA measures human antibodies against PAD3, PAD4, fibrinogen, citrullinated fibrinogen,…

The Big Pharma CEO Who’s Helping to Put an End to COVID-19

June 1, 2021

Most Americans don’t know his name. Before the announcement that his company had come up with a vaccine for COVID-19 that was 95 percent effective and was primed to manufacture millions of doses, fewer still knew much about the company he led—Pfizer—other than this: They didn’t like it. Or the industry in which he spent…

Sanofi to help manufacture Moderna COVID-19 vaccine, supporting global supply demands

June 1, 2021

Sanofi is the only company to leverage its manufacturing capacity and expertise to support three different COVID-19 vaccines to support the global supply of vaccines and help address the pandemic Sanofi to manufacture up to 200 million doses of Moderna’s vaccine in the U.S. starting in September 2021 MEDIA UPDATE – April 26, 2021 Sanofi…

Vestaron Announces New Sustainability Commitment

June 1, 2021

On Earth Day, peptide-based ag innovator shares sustainable vision April 22, 2021 – (Research Triangle Park, North Carolina) – Vestaron, a leader in the evolution of agricultural environmental science, is solidifying their commitment to sustainability through the launch of a new multi-faceted sustainability platform, emPOWERED by Purpose.  With powerful novel solutions, Vestaron’s peptide-based products provide growers with…

GreenMark Secures FDA Clearance for LumiCare Caries Detection Rinse

June 1, 2021

Enhanced Visualization of Dental Caries is the First Commercial Application of Startup Venture’s Nanotechnology Platform East Lansing & Ann Arbor, MI, April 8, 2021 – GreenMark Biomedical Inc. announced that the company has secured regulatory clearance from the U.S. Food and Drug Administration (FDA) to market its LumiCare™ Caries Detection Rinse as a 510(k) Class…

Validation & Compliance Institute Teams Up With NSF International to Help Dietary Supplement Quality

April 13, 2021

Validation & Compliance Institute and NSF International have formed an alliance to deliver Positive Compliance to the dietary supplement industry. Positive Compliance radically improves regulatory compliance while reducing costs. Learn more.

Ann Arbor SPARK to Manage Statewide Michigan Internship Program

April 1, 2021

The Michigan Economic Development Corporation (MEDC) will partner with Ann Arbor SPARK to launch the Michigan STEM Forward internship program on a statewide level. SPARK has run the program on a local level through the Ann Arbor/Ypsilanti SmartZone with a decade of positive results. In scaling the program up, MEDC will work in partnership with…

Michigan Health Information Network Kicks Off Virtual Event Series

April 1, 2021

First event focuses on implications of COVID-19, future of health care delivery GRAND RAPIDS, Mich. – Michigan Health Information Network Shared Services (MiHIN) yesterday kicked off their 2021 virtual event series, Connecting Michigan for Health and More. The series includes five virtual events over the course of the year, including a combination of full-day conferences…

Vestaron Announces Partnership with Bee Friendly Farming

April 1, 2021

March 24, 2021 – (Research Triangle Park, North Carolina) – Vestaron, a leader in the evolution of agricultural environmental science, is proud to announce a collaboration with Bee Friendly Farming® (BFF). This partnership represents the two groups’ shared mission to promote and protect honey bees and their vital role as agricultural pollinators. The BFF program…

GR company producing J and J vaccine ready for FDA approval

March 3, 2021

GRAND RAPIDS, Mich. (WOOD) — A Grand Rapids company is producing the next great hope for ending the pandemic. Grand River Aseptic Manufacturing is already making Johnson & Johnson’s one-shot COVID-19 vaccine, which is expected to get the green light from federal regulators any day now. “I don’t know if a lot of people have…

MiSTEM Playbook Pilot funding opportunity aims to expand education efforts across the state

March 3, 2021

LANSING, Mich.—The MiSTEM Network announced it will fund $100,000 in grants ($10,000 each) to STEM educators for usability testing of MiSTEM Playbooks that include real-world examples, advice, resources and best practices created by teachers, for teachers, needed to bring STEM learning to life – and cultivate our future workforce. The pilot grant opportunity will help…

Genemarkers LLC and Swift Biosciences Detect Unexpected Variant from COVID-19 S Gene Dropout Samples from Kalamazoo, MI

March 3, 2021

ANN ARBOR, Mich (February 17, 2021) Genemarkers LLC, leaders in genomic research from Kalamazoo, MI and Swift Biosciences, pioneers in the development of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS) systems in Ann Arbor, MI, collaborated together to detect mutations and variants from COVID-19 samples sourced in Kalamazoo, MI.  Genemarkers Senior Scientist…

Stryker sells T/Pump product line to C2Dx

March 3, 2021

Original Post: https://www.massdevice.com/stryker-sells-t-pump-product-line-to-c2dx/ C2Dx today announced that it has acquired Stryker’s T/Pump product line for an undisclosed amount. The T/Pump product line provides localized temperature therapy for pain relief and patient comfort. It is used for orthopedic conditions, acute injuries, chronic pain, and muscle strains. It can also be used for skin trauma, burns, contusions,…

Johnson and Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial

February 1, 2021

Written by Johnson & Johnson Media Contacts Vaccine Candidate 72% Effective in the US and 66% Effective Overall at Preventing Moderate to Severe COVID-19, 28 Days after Vaccination 85% Effective Overall in Preventing Severe Disease and Demonstrated Complete Protection Against COVID-19 related Hospitalization and Death as of Day 28 Protection Against Severe Disease Across Geographies,…

Stryker closes Wright Medical buy, sells some businesses to DJO

December 30, 2020

Story Originally Published by Mass Device here. Stryker (NYSE:SYK) announced that it has closed the purchase of Wright Medical (NSDQ:WMGI) and sold some of its arthroplasty systems to DJO. Kalamazoo, Mich.-based Stryker announced last week that it planned to complete the $4.7 billion tender offer at its expiration, which was scheduled for 5 p.m. ET on Nov. 10, 2020.…